Yanqin Wu

1.0k total citations
49 papers, 754 citations indexed

About

Yanqin Wu is a scholar working on Hepatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Yanqin Wu has authored 49 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 15 papers in Pathology and Forensic Medicine and 12 papers in Epidemiology. Recurrent topics in Yanqin Wu's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cancer Mechanisms and Therapy (7 papers). Yanqin Wu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cancer Mechanisms and Therapy (7 papers). Yanqin Wu collaborates with scholars based in China, Hong Kong and Czechia. Yanqin Wu's co-authors include Ruili Dang, Pei Jiang, LI Huan-de, Mimi Tang, Ying Xue, Wenzhe Fan, Hualin Cai, Jiaping Li, Xin He and Ling-Juan Cao and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Infectious Diseases and Nutrients.

In The Last Decade

Yanqin Wu

48 papers receiving 747 citations

Peers

Yanqin Wu
Agnieszka Korolczuk Poland
Xinjin Chi China
Cláudio Galeano Zettler Brazil
Xin Xin China
Balázs Tamás Németh Hungary
Wencheng Di China
Ximei Peng United States
Agnieszka Korolczuk Poland
Yanqin Wu
Citations per year, relative to Yanqin Wu Yanqin Wu (= 1×) peers Agnieszka Korolczuk

Countries citing papers authored by Yanqin Wu

Since Specialization
Citations

This map shows the geographic impact of Yanqin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqin Wu more than expected).

Fields of papers citing papers by Yanqin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanqin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqin Wu. The network helps show where Yanqin Wu may publish in the future.

Co-authorship network of co-authors of Yanqin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanqin Wu. A scholar is included among the top collaborators of Yanqin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanqin Wu. Yanqin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Bowen, Yanqin Wu, Rong Tang, et al.. (2024). DEB‐TACE versus cTACE for unresectable HCC with B1‐type bile duct invasion after successful biliary drainage: A propensity score matching analysis. Cancer Medicine. 13(13). e7419–e7419. 1 indexed citations
3.
Li, Na, et al.. (2024). Does mandatory operating information disclosure affect corporate earnings management? Evidence from China. Economic Analysis and Policy. 85. 768–790. 2 indexed citations
4.
5.
Wu, Yanqin, et al.. (2023). Identification of BRD7 by whole-exome sequencing as a predictor for intermediate-stage hepatocellular carcinoma in patients undergoing TACE. Journal of Cancer Research and Clinical Oncology. 149(13). 11247–11261. 2 indexed citations
6.
Wu, Yanqin, et al.. (2022). Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE. SHILAP Revista de lepidopterología. 4 indexed citations
7.
Fan, Wenzhe, Bowen Zhu, Mingjian Lu, et al.. (2022). Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization. Journal of Cancer Research and Clinical Oncology. 149(5). 1873–1882. 2 indexed citations
8.
Wu, Yanqin, et al.. (2022). Treatment Outcomes and Risk Factors of Multidrug-Resistant Tuberculosis Patients in Xi’an China, a Retrospective Cohort Study. Infection and Drug Resistance. Volume 15. 4947–4957. 5 indexed citations
9.
Peng, Ke, Feng Liu, Yijie Tang, et al.. (2022). Relationship between circadian genes and memory impairment caused by sleep deprivation. PeerJ. 10. e13165–e13165. 8 indexed citations
10.
Zhu, Bowen, Yanqin Wu, Lizhi Niu, et al.. (2020). Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling Pathway. Frontiers in Oncology. 10. 574383–574383. 8 indexed citations
11.
Wu, Yanqin, Wenzhe Fan, Jian Guo, et al.. (2020). Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma. Cancer Research and Treatment. 52(3). 925–937. 16 indexed citations
12.
Wang, Zhilei, Xinrui Wang, Yanqin Wu, et al.. (2019). Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma. Medical Oncology. 36(12). 97–97. 27 indexed citations
13.
Wu, Yanqin, Wenzhe Fan, Mengzhou Xue, et al.. (2019). 25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization. Clinical & Translational Oncology. 22(1). 70–80. 8 indexed citations
14.
Ye, Junzhao, Yanqin Wu, Congxiang Shao, et al.. (2019). Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study. Diabetology & Metabolic Syndrome. 11(1). 45–45. 17 indexed citations
15.
Fan, Wenzhe, Guosheng Yuan, Fuliang Li, et al.. (2019). Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Clinical Therapeutics. 41(8). 1463–1476. 39 indexed citations
16.
17.
18.
Dang, Ruili, Pei Jiang, Hualin Cai, et al.. (2015). Vitamin D deficiency exacerbates atypical antipsychotic-induced metabolic side effects in rats: Involvement of the INSIG/SREBP pathway. European Neuropsychopharmacology. 25(8). 1239–1247. 26 indexed citations
19.
Li, Sheng, Ying Xue, Xin He, et al.. (2015). Effects of repeated administration of rifampicin and isoniazid on vitamin D metabolism in mice. Steroids. 104. 203–207. 13 indexed citations
20.
Wu, Yanqin, et al.. (2009). [Effects of patient-controlled analgesia with small dose ketamine combined with morphine and the influence thereof on plasma beta-endorphin level in patients after radical operation for esophageal carcinoma].. PubMed. 89(5). 314–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnieszka Korolczuk Breakdown of academic impact, for papers by Xinjin Chi Breakdown of academic impact, for papers by Cláudio Galeano Zettler Breakdown of academic impact, for papers by Xin Xin Breakdown of academic impact, for papers by Balázs Tamás Németh Breakdown of academic impact, for papers by Wencheng Di Breakdown of academic impact, for papers by Ximei Peng
Rankless by CCL
2026